FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates 
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes 
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand 
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion 
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units 
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide 
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks 
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves 
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade 
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms 
Amazon Explores AI Content Marketplace With Media Publishers 
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility 
Global Bioenergies to present at the Microcap investors conference in New-York, on the 10th of April 2018
Evry, France - 06 April 2018 - Global Bioenergies to present at the Microcap investors conference in New-York, on the 10th of April 2018. For the First time in North America, the technology and business model of the company will be exposed in front of a selection of institutional investors.
About GLOBAL BIOENERGIES
Global Bioenergies is one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation. The Company initially focused its efforts on the production of isobutene, one of the most important petrochemical building blocks that can be converted into fuels, plastics, organic glass and elastomers. Global Bioenergies continues to improve the performance of its process, to operate its demo plant in Germany, and to prepare the first full-scale plant through a joint venture with Cristal Union, named IBN-One. Global Bioenergies is listed on Euronext Growth Paris (FR0011052257 - ALGBE).
Stay informed! Subscribe to our newsfeed on
www.global-bioenergies.com
Follow us on Twitter: @GlobalBioenergi
Contact
GLOBAL BIOENERGIES
Jean-Baptiste Barbaroux
Chief Corporate Officer
Phone: +33 1 64 98 20 50
[email protected]
Attachment
